Nicox Ophthalmics, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nicox Ophthalmics, Inc..The latest application filed is for "process for the preparation of sterile ophthalmic aqueous fluticasone propionate form a nanocrystals suspensions".

Company Profile

7.14.12

Nicox Ophthalmics, Inc. - Durham NC US
NICOX OPHTHALMICS, INC - Durham NC
Nicox Ophthalmics, Inc - Fort Worth TX US
NICOX OPHTHALMICS, INC. - Fort Worth TX US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process for the preparation of sterile ophthalmic aqueous fluticasone propionate form a nanocrystals suspensions Grant 11,406,596 - Bukowski , et al. August 9, 2	2022-08-09
Process For The Preparation Of Sterile Ophthalmic Aqueous Fluticasone Propionate Form A Nanocrystals Suspensions App 20220241296 - BUKOWSKI; Jean-Michel ; et al.	2022-08-04
Preparations Of Hydrophobic Therapeutic Agents, Methods Of Manufacture And Use Thereof App 20210300963 - CAVANAGH; Thomas ; et al.	2021-09-30
Ophthalmic Formulations Of Cetirizine And Methods Of Use App 20210290617 - ABELSON; Mark Barry ; et al.	2021-09-23
Compositions For The Treatment And Prevention Of Eyelid Swelling App 20210177807 - CHAPIN; Matthew Jonathan ; et al.	2021-06-17
Ophthalmic formulations of cetirizine and methods of use Grant 10,987,352 - Abelson , et al. April 27, 2	2021-04-27
Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof Grant 10,954,263 - Cavanagh , et al. March 23, 2	2021-03-23
Process For The Preparation Of Sterile Ophthalmic Aqueous Fluticasone Propionate Form A Nanocrystals Suspensions App 20210023001 - BUKOWSKI; Jean-Michel ; et al.	2021-01-28
Ophthalmic Formulations Of Cetirizine And Methods Of Use App 20200405711 - ABELSON; Mark Barry ; et al.	2020-12-31
Ophthalmic Formulations Of Cetirizine And Methods Of Use App 20200297719 - ABELSON; Mark Barry ; et al.	2020-09-24
Ophthalmic formulations of cetirizine and methods of use Grant 10,675,279 - Abelson , et al.	2020-06-09
Preparations Of Hydrophobic Therapeutic Agents, Methods Of Manufacture And Use Thereof App 20190169224 - CAVANAGH; Thomas ; et al.	2019-06-06
Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof Grant 10,174,071 - Cavanagh , et al. J	2019-01-08
Ophthalmic Formulations Of Cetirizine And Methods Of Use App 20180280383 - ABELSON; Mark Barry ; et al.	2018-10-04
Ophthalmic formulations of cetirizine and methods of use Grant 9,993,471 - Abelson , et al. June 12, 2	2018-06-12
Preparations Of Hydrophobic Therapeutic Agents, Methods Of Manufacture And Use Thereof App 20180022775 - CAVANAGH; Thomas ; et al.	2018-01-25
Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof Grant 9,822,142 - Cavanagh , et al. November 21, 2	2017-11-21
Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof Grant 9,815,865 - Barman , et al. November 14, 2	2017-11-14
Ophthalmic formulations of cetirizine and methods of use Grant 9,750,684 - Abelson , et al. September 5, 2	2017-09-05
Ophthalmic Formulations Of Cetirizine And Methods Of Use App 20170182035 - Abelson; Mark Barry ; et al.	2017-06-29
Compositions For The Treatment And Prevention Of Eyelid Swelling App 20170079957 - Chapin; Matthew Jonathan ; et al.	2017-03-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.